Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease

by Kasia Lobello, J. Michael Ryan, Enchi Liu, Gregory Rippon, Ronald Black
Published 2012-01-01

Trial Designs Likely to Meet Valid Long-Term Alzheimer's Disease Progression Effects: Learning from the Past, Preparing for the Future

by Aaron S. Kemp, George T. Grossberg, Steven J. Romano, Douglas L. Arnold, J. Michael Ryan, Roger Bullock, David L. Streiner
Published 2009-01-01

In vivo tau pathology is associated with synaptic loss and altered synaptic function

by Emma M. Coomans, Deborah N. Schoonhoven, Hayel Tuncel, Sander C. J. Verfaillie, Emma E. Wolters, Ronald Boellaard, Rik Ossenkoppele, Anouk den Braber, Wiep Scheper, Patrick Schober, Steven P. Sweeney, J. Michael Ryan, Robert C. Schuit, Albert D. Windhorst, Frederik Barkhof, Philip Scheltens, Sandeep S. V. Golla, Arjan Hillebrand, Alida A. Gouw, Bart N. M. van Berckel
Published 2021-02-01